Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
2022 Standout
Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
2019 Standout
Works of Claudia Corwin being referenced
RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1
2001
RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Claudia Corwin | 465 | 277 | 21 | 184 | 16 | 593 | |
| Leslie Rocher | 443 | 273 | 33 | 166 | 21 | 603 | |
| Elly M. van Duijnhoven | 512 | 282 | 22 | 149 | 10 | 641 | |
| John S. Najarian | 363 | 294 | 150 | 63 | 28 | 611 | |
| Nigel W. Brown | 243 | 92 | 13 | 124 | 25 | 543 | |
| M. Kohnle | 296 | 204 | 72 | 94 | 22 | 638 | |
| Yves F.C. Smets | 263 | 486 | 26 | 59 | 24 | 736 | |
| Phuong-Thu Pham | 379 | 295 | 107 | 52 | 22 | 674 | |
| Thomas R. McCune | 184 | 197 | 77 | 55 | 28 | 591 | |
| Leslie Anderson | 373 | 280 | 54 | 90 | 13 | 588 | |
| M. El-Shahawy | 387 | 374 | 42 | 79 | 11 | 641 |
All Works
Login with ORCID to disown or claim papers
Loading papers...